4.1 Estates Strategy
The School’s estates strategy is necessarily intertwined with the wider development of the Cambridge Biomedical Campus and in particular the Addenbrooke’s Hospital buildings, in which the University holds significant embedded space. A looming problem for the future is that much of the embedded space is provided with energy from the Hills Road substation which is at capacity; this will cap our energy draw at current levels in that space. Noting that the Clinical School is still the most densely occupied School estate at double (or greater) the rate of use of any other School (on 2014 Databook figures) the School is developing its Space Strategy driven by Academic goals and the need to recruit and retain the best staff (Risk 9) (Annex B). The School is eager to be involved in masterplanning for the Campus and welcomes the appointment of Michael Aston in Estates who is focussing on this (relevant to Risk 1 on the Register). An exciting possibility is the relocation of the Vet School to the Campus or close by, with opportunities to share new and expanded teaching and administration space and for research collaboration. If the Strangeways site could be decommissioned (see 4.6) we would be interested in discussing ways in which the site could be utilized for staff accommodation or other facilities to ease recruitment and retention issues, especially for postdocs and lower paid staff.
4.2 Project Gemma (ACRC) Green Zone
This building will provide additional space for clinical research and be located near to the ACCI. The construction phase started on 6th July 2015, scheduled to complete on 30th November2016. The final approved budget was £18.55M, with an outstanding unfunded underwrite by the School of circa £7M. Completion of fundraising is therefore urgent.
4.3 Project Bellatrix (TMTH) Green Zone
This new biological support facility for both the Schools of Clinical Medicine and Biological Sciences, will replace CBS which is reaching the end of its lifespan, and other smaller facilities on the Campus. The building is funded by the University’s Capital Fund as a necessary strategic development to support biological and biomedical research. The project was due to complete RIBA Stage 4 (Technical Design) at the end of November 2015 with construction following in January 2016, delivering a functional and Home Office approved facility in early 2018 at a total project cost is circa £105M. However, due to Planning Application issues raised during Pre Application meetings concerning the external appearance of the building along with its position on Plot 8 there have been significant delays resulting in considerable costs (comprising inflation and retaining fees). The delays in the build have had knock on effects regarding the tender process and after sending out tender documents and receiving / evaluating returns all tenders have been cancelled. The action being taken is:
- To reduce ongoing costs the main design and construction team have been stood down with the remaining team focus being fully on resolving any pre-application issues in order to gain planning approval in December/January;
- Once planning permission has been granted a project team can be reformed, with an initial task of reviewing the building scope to bring the project back into budget.
4.4 Project Capella (formerly 16,000m2, now 18,000m2 building) Green Zone
This building will house the Stem Cell Institute in collaboration with the School of Biological Sciences, and the School of Clinical Medicine initiatives in Haematopoiesis and the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) which will combine existing strengths in the department of Medicine with new recruitment. An addition during the past year has been the inclusion of space, enabled by a philanthropic donation, for a Therapeutics Institute led by Professor Kouzarides of the Gurdon Institute. RIBA Stage 4 (Technical Design) is due to finish at the end of January 2016 with a projected occupation date of early May 2018. However, some transport-related planning issues have been raised at a relatively late stage which is likely to delay granting of planning permission which will delay the programme further. Fundraising for the building still needs to be completed, however a £25M cornerstone grant for CITIID under the Research Partnership Infrastructure Fund (RPIF) scheme is in place. There may be an opportunity to resubmit an RPIF bid for the Stem Cell Institute following encouraging feedback in the last round. The total project cost is £94M and the School’s outstanding underwrite is £11M.
4.5 Atria (Heart and Lung Research Institute (HLRI)) Amber Zone
The School has plans to construct, jointly with Papworth Hospital NHS Foundation Trust, a Heart and Lung Research Institute situated alongside the new Hospital. At the end of RIBA Stage 3 (Developed Design) the project is now entering a pause phase to enable a fundraising campaign; construction will not start until almost all the funds required for the joint project are in place. A cornerstone grant from a major charity of up to £10M is in the process of agreement which will help leverage further philanthropic funds. A CUHP dedicated fundraiser for this project has been engaged. If the campaign is successful and construction could start in July 2017 as wished, the new facility would be ready for occupation in July 2019. The School believes that with the £10M capital grant in place together with the current extensive portfolio of funding held by the principal investigators, this project would be well-placed to make a successful RPIF bid in the next or following round and has started preparatory work to verify the funding assumptions so that the usually short deadlines for preliminary applications could be met.
4.6 Public Health, Blue Zone
The School remains committed to wishing to bring together the majority of Public Health groups within a physical Institute for Public Health, while recognizing that there are also substantial benefits of embedding some public health groups within a clinical or laboratory research environment – for example juxtaposed to cardiovascular groups. A building shared with the Trust, in particular with an outpatients facility, could have academic benefit. Providing vacated space could be re-provided, the School would envisage de-commissioning the Strangeways site.
4.7 Capella Phase II, Blue Zone
The School submitted a proposal to place “Capella Phase II”, i.e. a building utilizing the remaining planning capacity on the Project Capella/CRUK CI site for a Cambridge Institute for Nucleic Acid Dynamics” led by Professor Balasubramanian, Professor Wolf Reik of the Babraham Institute and Professor Eric Miska, with an additional opportunity for close and direct integration with an Early Detection Institute in which the CRUK CI has great interest, but which would be broadened to non-cancer disease. The funding basis for this project is not currently clear.
4.8 “Brain Village”, Cancer Centre and “Children’s Hospital”
The School wishes to consolidate Neuroscience, including Mental Health, on the Forvie site although this would only be possible when Public Health has vacated. The School would also wish to be fully involved should CUHNHSFT bring forward plans for a new Cancer Centre, new state-of-the-art clinical facilities for children or new Neurosciences and Emergency Department on the hospital’s expansion land. If it were possible to build a new Institute, for example on the old LMB1 site, we would envisage decommissioning the Strangeways site. However we recognize that without significant fundraising activity these projects have to take a lower priority compared with other projects already under construction or in advanced stages of fund-raising.
The Department of Paediatrics is keen to develop a vision for research that will help maximize the potential of new leading edge clinical facilities for children, including innovative experimental medicine and clinical investigation and new treatment options for children of the region. Paediatrics is a natural speciality in which to implement precision medicine by integrating genomic and other information for bespoke medical advice early in life and therefore developing a paradigm of preventive medicine.
The Departments of Clinical Neurosciences and Psychiatry are engaged in strategic discussions about the alignment of Neurosciences and Mental Health. The School would be keen to lead a bid in response to the MRC’s call in 2016 for a Dementia Research Institute, building on existing links with the Dementias Platform UK, new capital infrastructure investment and recent ARUK Drug Discovery Institute funding. The School has also supported a preliminary application to the Wellcome Trust for a new Centre in Translational Neuroscience and Mental Health, and is actively pursuing opportunities for philanthropic investment in this area. Taken together, these strategic developments could form the nucleus of a major new estate development for brain and mind sciences on the Forvie site, in close proximity to the substantially upgraded Wolfson Brain Imaging Centre (MRC Clinical Research Infrastructure awards 2014), the Herchel Smith Building and the Brain Repair Centre.
In cancer, there are significant philanthropic and partnership opportunities to be seized to fund a new clinical research and clinical build, with the aim of creating a world-class facility integrating research and genomic medicine into clinical care – another opportunity for developing precision medicine. Research output in cancer achieved 739 papers in 2015, 68 of which in journals with an Impact Factor greater than 20, so there is a great opportunity through new build to consolidate CRUK major centre status and achieve more impact on patient care.
4.9 Minor Works – Clifford Allbutt Building (CAB) and previous Centre for Protein Engineering (now CIMR Annexe)
The former Centre for Protein Engineering was refurbished and handed over in July 2015. Professor Rubinsztein occupies Level 3 with an ARUK-funded team (£10M five-year grant for a Drug Discovery Institute) which needed the chemistry facilities on that floor. This floor operates as a new Division of Translation Medicine of CIMR. The remainder of the building is due to be occupied by another major School research group although some additional works may be required to meet its needs.
4.10 Minor Works – Medicine
Refurbishment work is due to complete at Christmas 2015; complications arose due to asbestos management, extra fire compartmentalisation works and window repairs. This substantial project, jointly funded by the School with £1m from the University’s Minor Works fund, will modernize a large section of the Department of Medicine’s laboratories.
4.11 Minor Works – Conversion of former Clinical School workshops space and WBIC for installation of new scanners.
In 2014 the School was awarded a significant amount of money under the MRC’s Clinical Research Infrastructure call (£25M over three themes). The majority of the funds were targeted at the purchase and installation of a PET/MR, a 7T MRI and a Skyrafit MRI upgrade to an existing machine. In order to house these scanners, significant works will be undertaken in the WBIC and the former Clinical School workshops to provide sufficient space, power and operational requirements for the scanners. A complex series of interlinked projects is designed to deliver all three machines in situ by March 2016, commissioned and operational from June 2016. The project is funded by the MRC grant, with supporting monies from the University.
4.12 Minor Works/Capital Project – Clinical School Building Adaptation and Refurbishment.
The first cohort of students who will all (subject to satisfactory progress) complete their clinical training at Cambridge rather than transfer to London or Oxford started their preclinical course in Michaelmas 2014. Thus, in September 2017, the number of clinical students will begin to increase by approximately 100 per year over current levels until in September 2019 the full numbers will be achieved. The project will be funded by a loan to the School, to be repaid from the increased fee income to the University due to the larger number of students. We will:
- Refurbish the Clinical School building to create more small group teaching rooms (by replacing redundant print journal stock on Level 4 and forming flexible, dividable and modernized space on the ground floor) and a larger student common room. In addition, to provide a better educational experience, an e-learning suite is planned, available for both pathology and non-clinical teaching (for example structural biology, statistics, computational biology);
- Time the project for nine months between July 2016 and April 2017 so as not to disrupt Final MB exam preparation.
4.13 Minor Works – LMB1 refurbishment for Clinical School Offices temporary decant
As referred to in 4.12 above, the Clinical School building needs to be refurbished. To achieve this within the time window required not to disrupt assessment, all staff and teaching will need to decant from the building for nine months. The move will be a major project in itself, especially since the decant space in LMB1 is not ready. To de-risk the project, we will:
- Continue to work with Estates to achieve a cost-efficient refurbishment in LMB1;
- Explore sharing teaching and Library space in the Faculty of Education for the nine months, supplemented by hiring Homerton space when Education does not have capacity;
- Create a careful decant and re-occupation plan to minimize disruption to the School’s support services.
4.14 New Minor Works
Attached at Annex E are a set of new Minor Works applications, sifted by the School from a long-list for priority. These are: additional works to the former Clinical School Workshops (over and above basic strip out) to convert the first floor into “dry” space for the Department of Oncology; renovation of Laboratories in the Department of Surgery (embedded space); refurbishment of Levels 4, 5 & 6 of CIMR (contingent on a successful CIMR Centre bid); and refurbishment of staff welfare areas including toilets/showers in the Institute of Public Health to promote cycling to work. A further set of smaller Minor Works likely to cost under £50k each is also supported by the School but can be taken through the normal processes, namely: addition of air handling and replacement flooring in Obstetrics & Gynaecology embedded space; and reconfiguration of a photocopier room in the Herschel Smith building for Psychiatry/Neuroscience to create more office space.
4.15 “Green” Issues and Electricity Incentivisation Scheme
The School remains committed to trying to achieve “green” ways of working. However, we recognize that new buildings planned and the purchase of two new Imaging scanners (and an upgrade) are likely to increase, not decrease, electricity use.
- Undertake a major School-wide project on freezer capacity and use, to develop recommendations for greater electrical efficiency, effective use of off-site storage including resilience benefits, and good use of scarce space ;
- Plan for the new buildings’ entry to the Electricity Incentivisation scheme, and recruit older buildings such as CIMR as pilot sites for energy saving initiatives;
- Urge the University to take a more proactive stance on videoconferencing (and improve the accessibility of School videoconferencing facilities), especially when sections of the UAS and School administration move out of Mill Lane to Greenwich House, to eliminate unnecessary travel – achieving carbon and financial savings and boosting Clinical School staff productivity;
- Roll out the positive outcomes for the “green” stationery procurement project in the School Office to Departments as an example of good practice;
- Replace standard light bulbs with LED light tubes in the Department of Public Health – costly at approximately £40.00 per tube, but will save approximately 85% electricity and have a much longer user life than a standard tube.